{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:18:48Z","timestamp":1779322728666,"version":"3.51.4"},"reference-count":10,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"Bristol-Myers Squibb"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2017,7,3]]},"DOI":"10.1080\/13696998.2017.1302947","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T09:13:51Z","timestamp":1488791631000},"page":"687-691","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors"],"prefix":"10.1080","volume":"20","author":[{"given":"Jay","family":"Lin","sequence":"first","affiliation":[{"name":"Novosys Health, Green Brook, NJ, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinara","family":"Makenbaeva","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb, Princeton, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Lingohr-Smith","sequence":"additional","affiliation":[{"name":"Novosys Health, Green Brook, NJ, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Bilmes","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb, Princeton, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,3,12]]},"reference":[{"key":"CIT0001","first-page":"205","volume":"3","author":"Ramchandren R","year":"2009","journal-title":"Biologics"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25656"},{"key":"CIT0003","unstructured":"National Comprehensive Cancer Network Guidelines. Chronic myelogenous leukemia. v. 2.2017. January 19, 2017. Fort Washington, PA. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cml.pdf Accessed January 20, 2017"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.215"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23938"},{"key":"CIT0006","volume-title":"What is a serious adverse event","author":"US Food and Drug Administration."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.24"},{"key":"CIT0008","volume-title":"Introductory guide to MedDRA Version 15.0","author":"MedDRA Maintenance and Support Services Organization.","year":"2012"},{"key":"CIT0009","unstructured":"Russo CA, Andrews RM. Healthcare Cost and Utilization Project. Statistical Brief #51. Hospital stays for stroke and other cerebrovascular diseases, 2005. May 2008. Rockville, MD. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb51.jsp Accessed January 20, 2017"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.109.930735"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2017.1302947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T19:48:06Z","timestamp":1599421686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2017.1302947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,12]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7,3]]}},"alternative-id":["10.1080\/13696998.2017.1302947"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2017.1302947","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}